Model-Based Characterization of the Pharmacokinetics, Target Engagement Biomarkers, and Immunomodulatory Activity of PF-06342674, a Humanized mAb Against IL-7 Receptor-Α, in Adults With Type 1 Diabetes

AAPS Journal - United States
doi 10.1208/s12248-019-0401-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Immunomodulatory Activity of Humanized Anti–IL-7r Monoclonal Antibody RN168 in Subjects With Type 1 Diabetes

JCI insight
Medicine
2019English

Identification of Tetraspanin-7 as a Target of Autoantibodies in Type 1 Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Simulation-Based Engineering of Humanized SCFV Antibody Against hTNF-α

Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2020English

The Pharmacokinetics and Pharmacodynamics of Alogliptin in Children, Adolescents, and Adults With Type 2 Diabetes Mellitus

European Journal of Clinical Pharmacology
MedicinePharmacology
2016English

Population Pharmacokinetics of Subcutaneous and Intradermal Glucagon in Patients With Type 1 Diabetes

Clinical Therapeutics
Pharmacology
2015English

CETSA-based Target Engagement of Taxanes as Biomarkers for Efficacy and Resistance

Scientific Reports
Multidisciplinary
2019English

IL-7; IL-7 Receptor (IL-7R; CD127)

Science-Business eXchange
2013English

Predicting Type 1 Diabetes Using Biomarkers

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

A Longitudinal Study of Fear of Hypoglycaemia in Adults With Type 1 Diabetes

Endocrinology, Diabetes & Metabolism
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy